Fluocinonide and Relacorilant: Interaction Details

Brand names
Relacorilant
Lifyorli
Fluocinonide
Vanos
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Fluocinonide With Relacorilant

What can happen when they are taken together (rated Major)

Reduced relacorilant exposure and reduced of relacorilant, reduced glucocorticoids exposure and reduced efficacy of glucocorticoids

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving relacorilant together with glucocorticoids should be avoided, since the combination may lower exposure to relacorilant, to the glucocorticoids, or to both, and this can diminish the efficacy of each drug. When the two drugs must be given together, patients should be monitored for a loss of effectiveness of relacorilant and of the glucocorticoids. For patients receiving glucocorticoids for immunosuppression in organ transplantation, with relacorilant is .1

The Fluocinonide and Relacorilant Interaction, Explained

Relacorilant (Lifyorli) works by blocking the body's glucocorticoid receptor, the same receptor that steroid medicines like fluocinonide (Vanos) act on. Because they work against each other, each one can make the other work less well. Fluocinonide is a steroid cream or gel used on the skin for inflammation and itching.

The listed evidence for this is theoretical, but the label still advises avoiding the combination when possible. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor. They can review whether you need both and, if you do, watch closely to see that each one is still working for you.

Mechanism: Pharmacologic . Relacorilant is a selective glucocorticoid receptor , and fluocinonide is a topical GR . The documented effect is reduced exposure and of both agents. Direction is mutual loss of effect, not accumulation.

  • Evidence: theoretical. Onset unspecified. Systemic exposure from topical fluocinonide is typically limited, so clinical significance may depend on area, duration, occlusion, and skin integrity.
  • Management: avoid when possible. If unavoidable, monitor for reduced effectiveness of both drugs, and individualize therapy.
  • in patients on glucocorticoids for immunosuppression after organ transplantation.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fluocinonide and Relacorilant Interact

The likely mechanism

Pharmacologic

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Fluocinonide and Relacorilant Interaction

The usual approach is to avoid using these together if another option exists. Your care team may review whether both are needed, consider alternatives, or tailor your treatment.

  • Keep taking both exactly as prescribed until your prescriber advises otherwise.
  • If both are needed, your team may monitor you more closely for reduced effectiveness of each medicine.
  • Tell them if your skin condition is not improving, or if symptoms relacorilant treats seem to return.
  • Tell them if you have had an organ transplant, because this combination is for transplant immunosuppression.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fluocinonide or Relacorilant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Fluocinonide and Relacorilant: Common Questions

How serious is the Fluocinonide and Relacorilant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fluocinonide and Relacorilant interaction managed?

The usual approach is to avoid using these together if another option exists. Your care team may review whether both are needed, consider alternatives, or tailor your treatment. Keep taking both exactly as prescribed until your prescriber advises otherwise. If both are needed, your team may monitor you more closely for reduced effectiveness of each medicine. Tell them if your skin condition is not… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Fluocinonide and Relacorilant Interaction

Ask in your own words about taking Fluocinonide and Relacorilant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: LIFYORLI™ oral capsules, relacorilant oral capsules. Corcept Therapeutics Incorporated (Per Manufacturer), Redwood City, CA, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Fluocinonide and Relacorilant

Also serious with Relacorilant

Also serious with Fluocinonide

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.